292 related articles for article (PubMed ID: 26799697)
1. Validation of the revised International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in 585 Mayo Clinic patients.
Haider M; Gangat N; Lasho T; Abou Hussein AK; Elala YC; Hanson C; Tefferi A
Am J Hematol; 2016 Jun; 91(4):390-4. PubMed ID: 26799697
[TBL] [Abstract][Full Text] [Related]
2. External validation and clinical evaluation of the International Prognostic Score of Thrombosis for Essential Thrombocythemia (IPSET-thrombosis) in a large cohort of Chinese patients.
Fu R; Xuan M; Lv C; Zhang L; Li H; Zhang X; Zhang D; Sun T; Xue F; Liu X; Liang H; Zhang L; Yang R
Eur J Haematol; 2014 Jun; 92(6):502-9. PubMed ID: 24460750
[TBL] [Abstract][Full Text] [Related]
3. Validation of the IPSET score for thrombosis in patients with prefibrotic myelofibrosis.
Guglielmelli P; Carobbio A; Rumi E; De Stefano V; Mannelli L; Mannelli F; Rotunno G; Coltro G; Betti S; Cavalloni C; Finazzi MC; Thiele J; Cazzola M; Vannucchi AM; Barbui T
Blood Cancer J; 2020 Feb; 10(2):21. PubMed ID: 32098944
[TBL] [Abstract][Full Text] [Related]
4. [Essential thrombocythemia: baseline characteristics and risk factors for survival and thrombosis in a series of 214 patients].
Angona A; Alvarez-Larrán A; Bellosillo B; Martínez-Avilés L; Garcia-Pallarols F; Longarón R; Ancochea À; Besses C
Med Clin (Barc); 2015 Mar; 144(6):247-53. PubMed ID: 25192581
[TBL] [Abstract][Full Text] [Related]
5. Validation of previous prognostic models for thrombosis and exploration of modified models in patients with essential thrombocythemia.
Hashimoto Y; Nakamae H; Tanaka T; Omura H; Horiuchi M; Yoshimura T; Takakuwa T; Mugitani A; Hirose A; Nakamae M; Koh H; Hino M
Eur J Haematol; 2018 Oct; 101(4):508-513. PubMed ID: 29971894
[TBL] [Abstract][Full Text] [Related]
6. IPSET-Thrombosis Better Identifies Thrombosis-Free Survival: A Turkish Cohort.
Sevindik OG; Mersin S; Katgi A; Tunali S; Solmaz SM; Acar C; Alacacioglu I; Piskin O; Ozcan MA; Demirkan F; Undar B; Ozsan GH
Clin Lymphoma Myeloma Leuk; 2015 Jun; 15(6):e101-4. PubMed ID: 25790738
[TBL] [Abstract][Full Text] [Related]
7. Application of prognostic score IPSET-thrombosis in patients with essential thrombocythemia of a Brazilian public service.
Navarro LM; Trufelli DC; Bonito DR; Del Giglio A; Bollmann PW
Rev Assoc Med Bras (1992); 2016 Oct; 62(7):647-651. PubMed ID: 27925044
[TBL] [Abstract][Full Text] [Related]
8. [Clinical evaluation of the revised International Prognostic Score of Thrombosis for essential thrombocythemia (IPSET-thrombosis) in a cohort of 746 Chinese adult patients].
Fu RF; Li HY; Xue F; Liu XF; Liu W; Huang YT; Chen YF; Zhang LY; Zhang L; Yang RC
Zhonghua Xue Ye Xue Za Zhi; 2017 Feb; 38(2):92-96. PubMed ID: 28279030
[No Abstract] [Full Text] [Related]
9. Comparison between thrombotic risk scores in essential thrombocythemia and survival implications.
Santoro M; Accurso V; Mancuso S; Carlisi M; Raso S; Tarantino G; Di Piazza F; Perez A; Russo A; Siragusa S
Hematol Oncol; 2019 Oct; 37(4):434-437. PubMed ID: 31465530
[TBL] [Abstract][Full Text] [Related]
10. Gender and survival in essential thrombocythemia: A two-center study of 1,494 patients.
Tefferi A; Betti S; Barraco D; Mudireddy M; Shah S; Hanson CA; Ketterling RP; Pardanani A; Gangat N; Coltro G; Guglielmelli P; Vannucchi AM
Am J Hematol; 2017 Nov; 92(11):1193-1197. PubMed ID: 28795425
[TBL] [Abstract][Full Text] [Related]
11. Development and validation of an International Prognostic Score of thrombosis in World Health Organization-essential thrombocythemia (IPSET-thrombosis).
Barbui T; Finazzi G; Carobbio A; Thiele J; Passamonti F; Rumi E; Ruggeri M; Rodeghiero F; Randi ML; Bertozzi I; Gisslinger H; Buxhofer-Ausch V; De Stefano V; Betti S; Rambaldi A; Vannucchi AM; Tefferi A
Blood; 2012 Dec; 120(26):5128-33; quiz 5252. PubMed ID: 23033268
[TBL] [Abstract][Full Text] [Related]
12. Mutations and thrombosis in essential thrombocythemia: prognostic interaction with age and thrombosis history.
Gangat N; Wassie EA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Passamonti F; Tefferi A
Eur J Haematol; 2015 Jan; 94(1):31-6. PubMed ID: 24889737
[TBL] [Abstract][Full Text] [Related]
13. Validation of thrombotic risk factors in 1381 patients with essential thrombocythaemia: A multicentre retrospective real-life study.
Stuckey R; Ianotto JC; Santoro M; Czyż A; Perez Encinas MM; Gómez-Casares MT; Noya Pereira MS; de Nałęcz AK; Gołos A; Lewandowski K; Szukalski Ł; González-Martín JM; Wróbel T; Sobas MA
Br J Haematol; 2022 Oct; 199(1):86-94. PubMed ID: 35906782
[TBL] [Abstract][Full Text] [Related]
14. Risk of thrombosis in essential thrombocythemia according to three prediction models: an external validation study.
Saelue P; Thongsukhsai P
J Thromb Thrombolysis; 2023 Apr; 55(3):527-535. PubMed ID: 36652138
[TBL] [Abstract][Full Text] [Related]
15. Correlation between IPSET-t risk at diagnosis and subsequent hemorrhage in patients with essential thrombocythemia; a single institution experience.
Tosoni L; Liberi M; Morelli G; Zannier ME; Lazzarotto D; Filì C; Simeone E; Battaglia G; Callegari C; Fanin M; Damiani D; Fanin R; Tiribelli M
Ann Hematol; 2024 Feb; 103(2):443-448. PubMed ID: 38072850
[TBL] [Abstract][Full Text] [Related]
16. [Thrombotic events and significance of the IPSET thrombosis risk evaluation score in essential thrombocythaemia].
Pósfai É; Marton I; Nemes A; Borbényi Z
Orv Hetil; 2015 Apr; 156(14):558-63. PubMed ID: 25819149
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the effects between MPL and JAK2V617F on thrombosis and peripheral blood cell counts in patients with essential thrombocythemia: a meta-analysis.
Yang E; Wang M; Wang Z; Li Y; Wang X; Ming J; Xiao H; Quan R; Liu W; Hu X
Ann Hematol; 2021 Nov; 100(11):2699-2706. PubMed ID: 34383101
[TBL] [Abstract][Full Text] [Related]
18. The association of JAK2V617F mutation and leukocytosis with thrombotic events in essential thrombocythemia.
Hsiao HH; Yang MY; Liu YC; Lee CP; Yang WC; Liu TC; Chang CS; Lin SF
Exp Hematol; 2007 Nov; 35(11):1704-7. PubMed ID: 17920754
[TBL] [Abstract][Full Text] [Related]
19. Calreticulin mutation does not modify the IPSET score for predicting the risk of thrombosis among 1150 patients with essential thrombocythemia.
Finazzi G; Carobbio A; Guglielmelli P; Cavalloni C; Salmoiraghi S; Vannucchi AM; Cazzola M; Passamonti F; Rambaldi A; Barbui T
Blood; 2014 Oct; 124(16):2611-2. PubMed ID: 25323688
[No Abstract] [Full Text] [Related]
20. Analysis of risk factors predicting thrombotic and/or haemorrhagic complications in 306 patients with essential thrombocythemia.
Radaelli F; Colombi M; Calori R; Zilioli VR; Bramanti S; Iurlo A; Zanella A
Hematol Oncol; 2007 Sep; 25(3):115-20. PubMed ID: 17464935
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
